Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
Rianneke de RitterSimone J S SepCarla J H van der KallenMiranda T SchramAnnemarie KosterAbraham A KroonMarleen M J van GreevenbroekSimone J P M EussenPieter C DagnelieMarit de JongRimke C VosMark WoodwardMichiel L BotsSanne A E PetersCoen D A StehouwerPublished in: BMJ open diabetes research & care (2019)
Our results are consistent with the concept that the more adverse changes in cardiometabolic risk factors in women (than men) arise as a continuous process before the onset of type 2 diabetes.